News
Lexicon Announces Outcome of FDA Advisory Committee for ZynquistaTM (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
By: investing_za
- Nov 01 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS